NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning.
Shares of Celera jumped 3.3, or 7.9 percent, to 44.90 in morning trading, while shares of sister company Applied Biosystems were also up, rising 3.49, or 4.8 percent, to 76.40.
Celera’s main competitor in the data war, Incyte, was also up, albeit a more moderate 5/16, or 1.5 percent, at 20 13/16.
Shares of genomics drug-discovery companies Human Genome Sciences and Millennium were also higher in morning trading. Shares of Human Genome Sciences jumped 3 1/4, or 6.4 percent, to 54 5/16. Millennium’s shares were up 2 1/16, or 5.0 percent, at 43.
Genomics technology companies were also higher following the reactions to the morning announcement. Bioinformatics player Lion Biosciences was up 1 1/4, or 2.2 percent, at 59 1/4, while DNA chipmaker Affymetrix was up 4 3/32, or 6.5 percent, at 66 11/16.
But Third Wave Technologies, a maker of SNP detection tools, was down in its second day of trading. Shares were off 1/16, or 0.6 percent, at 11.
On Friday, Third Wave offered 7.5 million shares at $11 each. The company’s stock closed the day up 6 cents at $11.06.